Risk factors
Sensus Healthcare (SRTS) risk factors
Item 1A of every Sensus Healthcare, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors20 risks1 dropped2 reworded
Sensus reported a net loss of $7.7 million in 2025, breaking prior years of maintained profitability. The company dropped its smaller reporting company risk disclosure.
Filed Mar 04, 2026 - FY2024 10-K risk factors21 risks
Sensus Healthcare relies heavily on sales of its SRT-100 product line for non-melanoma skin cancer treatments. Operations depend on a single preferred supplier for x-ray tubes and third-party reimbursement coverage. Regulatory compliance under healthcare laws and FDA reporting is critical to ongoing business success.
Filed Mar 05, 2025